Article
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma.
Current cancer drug targets - 1 Jan 2020
Wang Yingyi, Jin Bao, Zhou Na, Sun Zhao, Li Jiayi, Chen Qiao, Wu Xiangan, Zhou Yi, Shi Yue, Lu Xin, Sang Xinting, Mao Yilei, Du Shunda, Wang Wenze, Bai Chunmei
Abstract excerpt
BACKGROUND: Neoantigens are newly formed antigens that have not been previously recognized by the immune system. They may arise from altered tumor proteins that form as a result of mutations. Although neoantigens have recently been linked to antitumor immunity in long-term survivors of cancers, such as melanoma and colorectal cancer, their prognostic and immune-modulatory role in many cancer types remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.